F Ponten

Summary

Publications

  1. pmc Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
    Patrick C O Leary
    UCD School of Biomolecular and Biomedical Science, UCD Conway Institute of Biomolecular and Biomedical Science, University College Dublin, Dublin 4, Ireland
    BMC Cancer 13:175. 2013
  2. pmc The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
    Catharina Medrek
    Center for Molecular Pathology, Skane University Hospital, Lund University, Malmo, Sweden
    BMC Cancer 12:306. 2012
  3. pmc A tool to facilitate clinical biomarker studies--a tissue dictionary based on the Human Protein Atlas
    Caroline Kampf
    Department of Immunology, Genetics, Pathology, Science for Life Laboratory, Uppsala University, Dag Hammarskjölds väg 20, Uppsala, 751 85 Sweden
    BMC Med 10:103. 2012
  4. pmc Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study
    Liv Jonsson
    Department of Clinical Sciences, Pathology, Lund University, Skane University Hospital, 221 85 Lund, Sweden
    J Transl Med 9:114. 2011
  5. doi request reprint The Human Protein Atlas as a proteomic resource for biomarker discovery
    F Ponten
    Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
    J Intern Med 270:428-46. 2011
  6. doi request reprint Profiling protein expression and interactions: proximity ligation as a tool for personalized medicine
    A Blokzijl
    Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
    J Intern Med 268:232-45. 2010
  7. doi request reprint The Human Protein Atlas--a tool for pathology
    F Ponten
    Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE 751 85 Uppsala, Sweden
    J Pathol 216:387-93. 2008

Collaborators

  • U Landegren
  • Mathias Uhlen
  • Emma Lundberg
  • M Friedman
  • Karin Jirstrom
  • Patrick C O Leary
  • Caroline Kampf
  • Catharina Medrek
  • Julia Bergman
  • Liv Jonsson
  • A Blokzijl
  • Sarah A Penny
  • William M Gallagher
  • Radoslaw Zagozdzon
  • Stephen F Madden
  • Catherine M Kelly
  • Amanda H McCann
  • Elton Rexhepaj
  • Roisin T Dolan
  • Michael J Duffy
  • Donal J Brennan
  • Malcolm R Kell
  • Per Oksvold
  • Karin Leandersson
  • Anna Asplund
  • Sanjay Navani
  • Mikaela Wiking
  • Björn Nodin
  • Jonas Manjer

Detail Information

Publications7

  1. pmc Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
    Patrick C O Leary
    UCD School of Biomolecular and Biomedical Science, UCD Conway Institute of Biomolecular and Biomedical Science, University College Dublin, Dublin 4, Ireland
    BMC Cancer 13:175. 2013
    ....
  2. pmc The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
    Catharina Medrek
    Center for Molecular Pathology, Skane University Hospital, Lund University, Malmo, Sweden
    BMC Cancer 12:306. 2012
    ..We also analyzed the prognostic value of the localization of CD163(+) and CD68(+) myeloid cells in human breast cancer...
  3. pmc A tool to facilitate clinical biomarker studies--a tissue dictionary based on the Human Protein Atlas
    Caroline Kampf
    Department of Immunology, Genetics, Pathology, Science for Life Laboratory, Uppsala University, Dag Hammarskjölds väg 20, Uppsala, 751 85 Sweden
    BMC Med 10:103. 2012
    ..Here, we explain how this dictionary can be used as a tool to aid clinicians and scientists in understanding the use of tissue histology and cancer pathology in diagnostics and biomarker studies...
  4. pmc Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study
    Liv Jonsson
    Department of Clinical Sciences, Pathology, Lund University, Skane University Hospital, 221 85 Lund, Sweden
    J Transl Med 9:114. 2011
    ..In this study, the prognostic value of immunohistochemical RBM3 expression was assessed in incident cases of malignant melanoma from a prospective population-based cohort study...
  5. doi request reprint The Human Protein Atlas as a proteomic resource for biomarker discovery
    F Ponten
    Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
    J Intern Med 270:428-46. 2011
    ....
  6. doi request reprint Profiling protein expression and interactions: proximity ligation as a tool for personalized medicine
    A Blokzijl
    Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
    J Intern Med 268:232-45. 2010
    ..The analysis of this extended range of biomarkers will prove critical for the development and implementation of personalized medicine...
  7. doi request reprint The Human Protein Atlas--a tool for pathology
    F Ponten
    Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE 751 85 Uppsala, Sweden
    J Pathol 216:387-93. 2008
    ..Thus, the presented Human Protein Atlas provides a resource for pathology-based biomedical research, including protein science and biomarker discovery...